RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati

Описание: Nutcracker Therapeutics is a preclinical biopharma company developing multimodal RNA-based therapeutics for HPV-driven tumors, T-cell lymphoma, and Genitourinary tumors. On this episode of the Business of Biotech, Chief Business Officer Geoff Nosrati, Ph.D. offers a comprehensive view of the RNA-based therapeutics landscape and sheds light on what he perceives as an advantageous position at Nutcracker — the capacity to manufacture RNA in-house. If you're curious about the expanding science behind RNA-based therapeutics and their application in biotech, this conversation with a scientist-turned-chief business officer (Nosrati earned his Ph.D. in Biochemistry and Molecular Biology) is a can't-miss episode.

Subscribe to the NEW #BusinessofBiotech newsletter for more real, honest, transparent interactions with the leaders of emerging biotech. It's a once-per-month dose of insight and intel that you'll actually look forward to receiving! Check it out at www.bioprocessonline.com/bob.

#businessofbiotech #biopharma #biotech #cytiva

http://cytiva.com/emergingbiotech

Get notified when new episodes come out: https://www.bioprocessonline.com/bob

Audio version available here: https://www.bioprocessonline.com/doc/...

Subscribe to the podcast:

Apple - https://podcasts.apple.com/us/podcast...
Spotify - https://open.spotify.com/show/5NhjpDe...
Google - https://podcasts.google.com/?q=busine...